1-7 of 7
Mark Gurney
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Relevance of Truncating ASXL1 Mutations and ASXL1 -Integrated Molecular Models in Proliferative CMML

Clifford M Csizmar, Mark Gurney, Terra L Lasho, Rashmi Kanagal-Shamanna, Kelly S. Chien, Danielle E. Hammond, Christy M Finke, Abhishek A Mangaonkar, Aref Al-Kali, Naseema Gangat, Ayalew Tefferi, Hassan Alkhateeb, Guillermo Garcia-Manero, Guillermo Montalban-Bravo, Mrinal M. Patnaik
Journal: Blood
Blood (2023) 142 (Supplement 1): 3241.
https://doi.org/10.1182/blood-2023-186881
Published: 2023
Journal Articles

ASXL1 / TET2 Genotype-Based Risk Stratification Outperforms ASXL1 Mutational Impact and Is Independent of Mutant Variant Allele Fractions (VAF) in CMML

Clifford M Csizmar, Mark Gurney, Rashmi Kanagal-Shamanna, Kelly S. Chien, Danielle E. Hammond, Terra L Lasho, Christy M Finke, Christopher Dean, Abhishek A Mangaonkar, Naseema Gangat, Ayalew Tefferi, Hassan Alkhateeb, Guillermo Garcia-Manero, Guillermo Montalban-Bravo, Mrinal M. Patnaik
Journal: Blood
Blood (2023) 142 (Supplement 1): 4615.
https://doi.org/10.1182/blood-2023-187235
Published: 2023
Journal Articles

Clinical and Molecular Characteristics of ETV6 Mutated Myeloid Malignancies

Mark Gurney, Ismahene Chekkaf, Rong He, David S. Viswanatha, Patricia Greipp, Abhishek A. Mangaonkar, Kebede Begna, Naseema Gangat, Mrinal M. Patnaik, Mark R. Litzow, James M. Foran, Talha Badar, Mithun V. Shah, Hassan B. Alkhateeb, Aref Al-Kali
Journal: Blood
Blood (2022) 140 (Supplement 1): 6912–6914.
https://doi.org/10.1182/blood-2022-170641
Published: 2022
Journal Articles

TRAIL Engineering Enhances Expanded Cord Blood NK Cell Anti-Leukemic Activity

Mark Gurney, Margaret Twohig, Derya Goksu Helvaci, Eimear O'Reilly, Sarah Brophy, Janusz Krawczyk, David L. Hermanson, Eva Szegezdi, Michael E. O'Dwyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 10249–10250.
https://doi.org/10.1182/blood-2022-165517
Published: 2022
Journal Articles

Tc Buster Transposon Engineered CLL-1 CAR-NK Cells Efficiently Target Acute Myeloid Leukemia

Mark Gurney, Eimear O'Reilly, Sarah Corcoran, Sarah Brophy, David Hardwicke, Janusz Krawczyk, David Hermanson, Richard W. Childs, Eva Szegezdi, Michael E. O'Dwyer
Journal: Blood
Blood (2021) 138 (Supplement 1): 1725.
https://doi.org/10.1182/blood-2021-147244
Published: 2021
Journal Articles

Targeting CD38 high Acute Myeloid Leukaemia with "Affinity Optimized" Chimeric Antigen Receptor and Membrane Bound TRAIL Expressing Natural Killer Cells

Emma Nolan, BSc, Arwen Stikvoort, PhD, Mark Gurney, MD, Nutsa Burduli, BSc, Lucy Kirkham-McCarthy, MSc, John Daly, MSc, Niels W. C. J. Van De Donk, Tuna Mutis, MD PhD, Subhashis Sarkar, PhD, Michael E O'Dwyer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5536.
https://doi.org/10.1182/blood-2019-128605
Published: 2019
Journal Articles

The 2016 Revised World Health Organization Classification of 'Myelodysplastic Syndrome with Isolated Del(5q)'; Prognostic Implications of Single Versus Double Cytogenetic Abnormalities

Mark Gurney, M.B B.Ch., Mrinal M Patnaik, MBBS, Curtis A. Hanson, MD, Mark R. Litzow, MD, Aref Al-Kali, MD, Rhett P. Ketterling, MD, Ayalew Tefferi, MD, Naseema Gangat, MBBS
Journal: Blood
Blood (2016) 128 (22): 5542.
https://doi.org/10.1182/blood.V128.22.5542.5542
Published: 2016